{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T16:36:29Z","timestamp":1717518989200},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10014-015-0221-9","type":"journal-article","created":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T07:20:56Z","timestamp":1430378456000},"page":"163-168","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Involvement of epimutations in meningioma"],"prefix":"10.1007","volume":"32","author":[{"given":"Mario","family":"Venza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Visalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concetta","family":"Beninati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Biondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Teti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Venza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,1]]},"reference":[{"key":"221_CR1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg962","volume":"3","author":"PA Jones","year":"2002","unstructured":"Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415\u2013428","journal-title":"Nat Rev Genet"},{"key":"221_CR2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/156800911794328510","volume":"11","author":"LR Ferguson","year":"2011","unstructured":"Ferguson LR, Tatham AL, Lin Z, Denny WA (2011) Epigenetic regulation of gene expression as an anticancer drug target. Curr Cancer Drug Targets 11:199\u2013212","journal-title":"Curr Cancer Drug Targets"},{"key":"221_CR3","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.4161\/epi.22446","volume":"7","author":"I Venza","year":"2012","unstructured":"Venza I, Visalli M, Fortunato C et al (2012) PGE2 induces interleukin-8 derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation. Epigenetics 7:1315\u20131330","journal-title":"Epigenetics"},{"key":"221_CR4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbagrm.2014.12.004","volume":"1849","author":"M Venza","year":"2014","unstructured":"Venza M, Visalli M, Biondo C et al (2014) Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma. Biochim Biophys Acta 1849:247\u2013256","journal-title":"Biochim Biophys Acta"},{"key":"221_CR5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.tiv.2014.10.020","volume":"29","author":"M Venza","year":"2015","unstructured":"Venza M, Visalli M, Biondo C et al (2015) Epigenetic marks responsible for cadmium-induced melanoma cell overgrowth. Toxicol In Vitro 29:242\u2013250","journal-title":"Toxicol In Vitro"},{"key":"221_CR6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.intimp.2014.05.024","volume":"21","author":"I Venza","year":"2014","unstructured":"Venza I, Visalli M, Oteri R, Teti D, Venza M (2014) Class I-specific histone deacetylase inhibitor MS-275 overrides TRAIL-resistance in melanoma cells by downregulating c-FLIP. Int Immunopharmacol 21:439\u2013446","journal-title":"Int Immunopharmacol"},{"key":"221_CR7","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1177\/1430.15828","volume":"100","author":"M Venza","year":"2014","unstructured":"Venza M, Dell\u2019Aversana C, Visalli M, Altucci L, Teti D, Venza I (2014) Identification of microRNA expression patterns in cutaneous and uveal melanoma cell lines. Tumori 100:e4\u2013e7","journal-title":"Tumori"},{"key":"221_CR8","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.bbrc.2013.10.114","volume":"441","author":"M Venza","year":"2013","unstructured":"Venza M, Visalli M, Catalano T et al (2013) Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma. Biochem Biophys Res Commun 441:743\u2013750","journal-title":"Biochem Biophys Res Commun"},{"key":"221_CR9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/pcmr.12049","volume":"26","author":"I Venza","year":"2013","unstructured":"Venza I, Visalli M, Oteri R, Cucinotta M, Teti D, Venza M (2013) Class II-specific histone deacetylase inhibitors MC1568 and MC1575 suppress IL-8 expression in human melanoma cells. Pigment Cell Melanoma Res 26:193\u2013204","journal-title":"Pigment Cell Melanoma Res"},{"key":"221_CR10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1677\/JME-10-0043","volume":"45","author":"A Nebbioso","year":"2012","unstructured":"Nebbioso A, Dell\u2019Aversana C, Bugge A et al (2012) HDACs class II-selective inhibition alters nuclear receptor-dependent differentiation. J Mol Endocrinol 45:219\u2013228","journal-title":"J Mol Endocrinol"},{"key":"221_CR11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jcp.22236","volume":"225","author":"G Bernardo Di","year":"2010","unstructured":"Di Bernardo G, Alessio N, Dell\u2019Aversana C et al (2010) Impact of histone deacetylase inhibitors SAHA and MS-275 on DNA repair pathways in human mesenchymal stem cells. J Cell Physiol 225:537\u2013544","journal-title":"J Cell Physiol"},{"key":"221_CR12","first-page":"5187","volume":"34","author":"S Iwahashi","year":"2014","unstructured":"Iwahashi S, Utsunomiya T, Imura S et al (2014) Effects of valproic acid in combination with S-1 on advanced pancreatobiliary tract cancers: clinical study phases I\/II. Anticancer Res 34:5187\u20135191","journal-title":"Anticancer Res"},{"key":"221_CR13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00280-014-2501-1","volume":"74","author":"C Xia","year":"2014","unstructured":"Xia C, Leon-Ferre R, Laux D et al (2014) Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide). Cancer Chemother Pharmacol 74:691\u2013697","journal-title":"Cancer Chemother Pharmacol"},{"key":"221_CR14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1227\/NEU.0b013e31821954c6","volume":"69","author":"M Venza","year":"2011","unstructured":"Venza M, Visalli M, Alafaci C et al (2011) Interleukin-8 overexpression in astrocytomas is induced by prostaglandin E2 and is associated with the transcription factors CCAAT\/enhancer-binding protein-\u03b2 and CCAAT\/enhancer-binding homologous protein. Neurosurgery 69:713\u2013721 (discussion 721)","journal-title":"Neurosurgery"},{"key":"221_CR15","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3390\/ijms14012135","volume":"14","author":"M Caffo","year":"2013","unstructured":"Caffo M, Barresi V, Caruso G et al (2013) Innovative therapeutic strategies in the treatment of brain metastases. Int J Mol Sci 14:2135\u20132174","journal-title":"Int J Mol Sci"},{"key":"221_CR16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2174\/138920291506150106151847","volume":"15","author":"M Caffo","year":"2014","unstructured":"Caffo M, Caruso G, La Fata G et al (2014) Heavy metals and epigenetic alterations in brain tumors. Curr Genomics 15:457\u2013463","journal-title":"Curr Genomics"},{"key":"221_CR17","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3171\/jns.1992.77.4.0616","volume":"77","author":"H Maier","year":"1992","unstructured":"Maier H, Ofner D, Hittmair A, Kitz K, Budka H (1992) Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 77:616\u2013623","journal-title":"J Neurosurg"},{"key":"221_CR18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3171\/2012.3.JNS111945","volume":"117","author":"S Oya","year":"2012","unstructured":"Oya S, Kawai K, Nakatomi H, Saito N (2012) Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas. J Neurosurg 117:121\u2013128","journal-title":"J Neurosurg"},{"key":"221_CR19","first-page":"9","volume":"22","author":"JS You","year":"2010","unstructured":"You JS, Jones PA (2010) Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 22:9\u201320","journal-title":"Cancer Cell"},{"key":"221_CR20","doi-asserted-by":"crossref","first-page":"e54114","DOI":"10.1371\/journal.pone.0054114","volume":"8","author":"F Gao","year":"2013","unstructured":"Gao F, Shi L, Russin J et al (2013) DNA methylation in the malignant transformation of meningiomas. PLoS One 8:e54114","journal-title":"PLoS One"},{"key":"221_CR21","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/2013.10.FOCUS13360","volume":"35","author":"S He","year":"2013","unstructured":"He S, Pham MH, Pease M et al (2013) A review of epigenetic and gene expression alterations associated with intracranial meningiomas. Neurosurg Focus 35:E5. doi: 10.3171\/2013.10.FOCUS13360","journal-title":"Neurosurg Focus"},{"key":"221_CR22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11060-010-0411-6","volume":"103","author":"JA Kandenwein","year":"2011","unstructured":"Kandenwein JA, Park-Simon TW, Schramm J, Simon M (2011) uPA\/PAI-1 expression and uPA promoter methylation in meningiomas. J Neurooncol 103:533\u2013539","journal-title":"J Neurooncol"},{"key":"221_CR23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1593\/neo.121334","volume":"15","author":"KK Velpula","year":"2013","unstructured":"Velpula KK, Gogineni VR, Nalla AK, Dinh DH, Rao JS (2013) Radiation-induced hypomethylation triggers urokinase plasminogen activator transcription in meningioma cells. Neoplasia 15:192\u2013203","journal-title":"Neoplasia"},{"key":"221_CR24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/carcin\/bgr260","volume":"33","author":"Y Kishida","year":"2012","unstructured":"Kishida Y, Natsume A, Kondo Y et al (2012) Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses. Carcinogenesis 33:436\u2013441","journal-title":"Carcinogenesis"},{"key":"221_CR25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","volume":"17","author":"H Noushmehr","year":"2010","unstructured":"Noushmehr H, Weisenberger DJ, Diefes K et al (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17:510\u2013522","journal-title":"Cancer Cell"},{"key":"221_CR26","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3171\/2013.7.JNS13311","volume":"119","author":"J Vengoechea","year":"2013","unstructured":"Vengoechea J, Sloan AE, Chen Y et al (2013) Methylation markers of malignant potential in meningiomas. J Neurosurg 119:899\u2013906","journal-title":"J Neurosurg"},{"key":"221_CR27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.trsl.2012.05.007","volume":"160","author":"A Vinci Di","year":"2012","unstructured":"Di Vinci A, Brigati C, Casciano I et al (2012) HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomas. Transl Res 160:355\u2013362","journal-title":"Transl Res"},{"key":"221_CR28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.humpath.2005.02.006","volume":"36","author":"Y Liu","year":"2005","unstructured":"Liu Y, Pang JC, Dong S, Mao B, Poon WS, Ng HK (2005) Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas. Hum Pathol 36:416\u2013425","journal-title":"Hum Pathol"},{"key":"221_CR29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0165-4608(03)00244-9","volume":"148","author":"J Lomas","year":"2004","unstructured":"Lomas J, Ami\u00f1oso C, Gonzalez-Gomez P et al (2004) Methylation status of TP73 in meningiomas. Cancer Genet Cytogenet 148:148\u2013151","journal-title":"Cancer Genet Cytogenet"},{"key":"221_CR30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3171\/JNS-07\/08\/0398","volume":"107","author":"Y Nakane","year":"2007","unstructured":"Nakane Y, Natsume A, Wakabayashi T et al (2007) Malignant transformation-related genes in meningiomas: allelic loss on 1p36 and methylation status of p73 and RASSF1A. J Neurosurg 107:398\u2013404","journal-title":"J Neurosurg"},{"key":"221_CR31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/humu.22562","volume":"35","author":"T Soussi","year":"2014","unstructured":"Soussi T (2014) The TP53 gene network in a postgenomic era. Hum Mutat 35:641\u2013642","journal-title":"Hum Mutat"},{"key":"221_CR32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4238\/vol8-1gmr518","volume":"8","author":"LO Almeida","year":"2009","unstructured":"Almeida LO, Cust\u00f3dio AC, Pinto GR et al (2009) Polymorphisms and DNA methylation of gene TP53 associated with extra-axial brain tumors. Genet Mol Res 8:8\u201318","journal-title":"Genet Mol Res"},{"key":"221_CR33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1215\/15228517-2008-096","volume":"11","author":"P Jun","year":"2009","unstructured":"Jun P, Hong C, Lal A et al (2009) Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific. Neuro Oncol 11:414\u2013422","journal-title":"Neuro Oncol"},{"key":"221_CR34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00401-004-0911-6","volume":"108","author":"MJ Bello","year":"2004","unstructured":"Bello MJ, Ami\u00f1oso C, Lopez-Marin I et al (2004) DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q. Acta Neuropathol 108:413\u2013421","journal-title":"Acta Neuropathol"},{"key":"221_CR35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/gtmb.2011.0245","volume":"16","author":"F Aydemir","year":"2012","unstructured":"Aydemir F, Yurtcu E, Balci TB, Sahin FI, Gulsen S, Altinors N (2012) Identification of promoter region methylation patterns of MGMT, CDKN2A, GSTP1, and THBS1 genes in intracranial meningioma patients. Genet Test Mol Biomark 16:335\u2013340","journal-title":"Genet Test Mol Biomark"},{"key":"221_CR36","doi-asserted-by":"crossref","first-page":"e94987","DOI":"10.1371\/journal.pone.0094987","volume":"9","author":"S Linsler","year":"2014","unstructured":"Linsler S, Kraemer D, Driess C et al (2014) Molecular biological determinations of meningioma progression and recurrence. PLoS One 9:e94987","journal-title":"PLoS One"},{"key":"221_CR37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbrc.2013.02.044","volume":"433","author":"H Ando","year":"2013","unstructured":"Ando H, Natsume A, Iwami K et al (2013) A hypoxia-inducible factor (HIF)-3\u03b1 splicing variant, HIF-3\u03b14 impairs angiogenesis in hypervascular malignant meningiomas with epigenetically silenced HIF-3\u03b14. Biochem Biophys Res Commun 433:139\u2013144","journal-title":"Biochem Biophys Res Commun"},{"key":"221_CR38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1750-3639.2009.00340.x","volume":"20","author":"D Barski","year":"2010","unstructured":"Barski D, Wolter M, Reifenberger G, Riemenschneider MJ (2010) Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas. Brain Pathol 20:623\u2013631","journal-title":"Brain Pathol"},{"key":"221_CR39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.matbio.2012.11.010","volume":"32","author":"DJ Lindner","year":"2013","unstructured":"Lindner DJ, Wu Y, Haney R et al (2013) Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis. Matrix Biol 32:123\u2013132","journal-title":"Matrix Biol"},{"key":"221_CR40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/PAT.0b013e328353a0ff","volume":"44","author":"AM Cesinaro","year":"2012","unstructured":"Cesinaro AM, Sartori G, Migaldi M et al (2012) Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas. Pathology 44:313\u2013317","journal-title":"Pathology"},{"key":"221_CR41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2990.2000.00219.x","volume":"26","author":"T Santarius","year":"2000","unstructured":"Santarius T, Kirsch M, Nikas DC, Imitola J, Black PM (2000) Molecular analysis of alterations of the p18INK4c gene in human meningiomas. Neuropathol Appl Neurobiol 26:67\u201375","journal-title":"Neuropathol Appl Neurobiol"},{"key":"221_CR42","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neulet.2005.01.050","volume":"380","author":"FF Costa","year":"2005","unstructured":"Costa FF, Colin C, Shinjo SM et al (2005) ADAM23 methylation and expression analysis in brain tumors. Neurosci Lett 380:260\u2013264","journal-title":"Neurosci Lett"},{"key":"221_CR43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11845-013-1001-3","volume":"183","author":"CB Avci","year":"2014","unstructured":"Avci CB, Dodurga Y, Susluer SY et al (2014) Promoter hypermethylation-mediated down-regulation of RUNX3 gene in human brain tumors. Ir J Med Sci 183:259\u2013264","journal-title":"Ir J Med Sci"},{"key":"221_CR44","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-05-0043","volume":"65","author":"EA Lusis","year":"2005","unstructured":"Lusis EA, Watson MA, Chicoine MR et al (2005) Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res 65:7121\u20137126","journal-title":"Cancer Res"},{"key":"221_CR45","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1227\/01.NEU.0000325488.72518.9E","volume":"63","author":"GR Hankins","year":"2008","unstructured":"Hankins GR, Sasaki T, Lieu AS et al (2008) Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor. Neurosurgery 63:771\u2013780 (discussion 780\u2013781)","journal-title":"Neurosurgery"},{"key":"221_CR46","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/gcc.20141","volume":"42","author":"J Lomas","year":"2005","unstructured":"Lomas J, Bello MJ, Arjona D et al (2005) Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas. Genes Chromosomes Cancer 42:314\u2013319","journal-title":"Genes Chromosomes Cancer"},{"key":"221_CR47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2164-8-16","volume":"8","author":"CM Hansson","year":"2007","unstructured":"Hansson CM, Buckley PG, Grigelioniene G et al (2007) Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus. BMC Genom 8:16","journal-title":"BMC Genom"},{"key":"221_CR48","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-09-3885","volume":"70","author":"X Zhang","year":"2010","unstructured":"Zhang X, Gejman R, Mahta A et al (2010) Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res 70:2350\u20132358","journal-title":"Cancer Res"},{"key":"221_CR49","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.4238\/2012.August.17.7","volume":"11","author":"MN Chen","year":"2012","unstructured":"Chen MN, Wang P, Zhang J, Zhou BY, Mao Q, Liu YH (2012) Analysis of the role of hMLH1 hypermethylation and microsatellite instability in meningioma progression. Genet Mol Res 11:3933\u20133941","journal-title":"Genet Mol Res"},{"key":"221_CR50","volume-title":"DNA methylation and histone deacetylation: interplay and combined therapy in cancer","author":"Y Qiu","year":"2012","unstructured":"Qiu Y, Shabashvili D, Li X, Gopalan PK, Chen M, Zajac-Kaye M (2012) DNA methylation and histone deacetylation: interplay and combined therapy in cancer. InTech, Rijeka"},{"key":"221_CR51","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/neuonc\/nor072","volume":"13","author":"ML Bush","year":"2011","unstructured":"Bush ML, Oblinger J, Brendel V et al (2011) AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas. Neuro Oncol 13:983\u2013999","journal-title":"Neuro Oncol"},{"key":"221_CR52","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/0008-5472.CAN-12-1888","volume":"73","author":"SS Burns","year":"2013","unstructured":"Burns SS, Akhmametyeva EM, Oblinger JL (2013) Histone deacetylase inhibitor AR-42 differentially affects cell-cycle transit in meningeal and meningioma cells, potently inhibiting NF2-deficient meningioma growth. Cancer Res 73:792\u2013803","journal-title":"Cancer Res"},{"key":"221_CR53","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0404.2006.00590.x","volume":"113","author":"M Olivera","year":"2006","unstructured":"Olivera M, Mart\u00ednez C, Molina JA et al (2006) Increased frequency of rapid acetylator genotypes in patients with brain astrocytoma and meningioma. Acta Neurol Scand 113:322\u2013326","journal-title":"Acta Neurol Scand"},{"key":"221_CR54","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.biocel.2009.09.016","volume":"42","author":"K Breving","year":"2010","unstructured":"Breving K, Esquela-Kerscher A (2010) The complexities of microRNA regulation: mirandering around the rules. Int J Biochem Cell Biol 42:1316\u20131329","journal-title":"Int J Biochem Cell Biol"},{"key":"221_CR55","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejca.2014.12.007","volume":"51","author":"CH Gattolliat","year":"2015","unstructured":"Gattolliat CH, Uguen A, Pesson M et al (2015) MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas. Eur J Cancer 51:409\u2013420","journal-title":"Eur J Cancer"},{"key":"221_CR56","author":"JY Tsang","year":"2015","unstructured":"Tsang JY, Ni YB, Ng EK et al (2015) MicroRNAs are differentially deregulated in mammary malignant phyllodes tumor. Histopathology. doi: 10.1111\/his.12648","journal-title":"Histopathology"},{"key":"221_CR57","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA et al (2005) MicroRNA expression profiles classify human cancers. Nature 435:834\u2013838","journal-title":"Nature"},{"key":"221_CR58","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.gde.2012.02.008","volume":"22","author":"J Sandoval","year":"2012","unstructured":"Sandoval J, Esteller M (2012) Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 22:50\u201355","journal-title":"Curr Opin Genet Dev"},{"key":"221_CR59","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857\u2013866","journal-title":"Nat Rev Cancer"},{"key":"221_CR60","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1038\/onc.2012.468","volume":"32","author":"N Kliese","year":"2013","unstructured":"Kliese N, Gobrecht P, Pachow D et al (2013) miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells. Oncogene 32:4712\u20134720","journal-title":"Oncogene"},{"key":"221_CR61","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1128\/MCB.00332-09","volume":"29","author":"O Saydam","year":"2009","unstructured":"Saydam O, Shen Y, W\u00fcrdinger T et al (2009) Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt\/beta-catenin signaling pathway. Mol Cell Biol 29:5923\u20135940","journal-title":"Mol Cell Biol"},{"key":"221_CR62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11060-012-0951-z","volume":"110","author":"L Shi","year":"2012","unstructured":"Shi L, Jiang D, Sun G et al (2012) miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas. J Neurooncol 110:155\u2013162","journal-title":"J Neurooncol"},{"key":"221_CR63","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ijc.27658","volume":"132","author":"F Zhi","year":"2013","unstructured":"Zhi F, Zhou G, Wang S et al (2013) A microRNA expression signature predicts meningioma recurrence. Int J Cancer 132:128\u2013136","journal-title":"Int J Cancer"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-015-0221-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10014-015-0221-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-015-0221-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T05:39:53Z","timestamp":1566625193000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10014-015-0221-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,1]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["221"],"URL":"https:\/\/doi.org\/10.1007\/s10014-015-0221-9","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,1]]}}}